tirzepatide drug shortage Lilly's weight-loss removed from FDA's list Semaglutide and Tirzepatide No Longer

Common side effects may include: Gastrointestinal Issues: Nausea, vomiting, diarrhea, and constipation are among the most frequently reported

The brand uses these terms to describe what's available

It is extensively studied in molecular and regenerative research for its role in cellular signalling, tissue organisation, and biological repair pathways

Switching patterns following formulary change Switching from AOM tirzepatide remained rare prior to May 2025, averaging 0.6% of patients who switched to a different GLP-1 in the following month

Nature 593, 586590

Side Effects and Their Impact on Donation The primary reason a person on Zepbound might be turned away from a blood donation site is not the medication itself, but the side effects